Schrodinger Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Schrodinger Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 โ Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SDGR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001490978
- EIN
- 95-4284541
Board of directors
-
Arun Oberoi ยท DirectorSince 2023
-
Gary L. Ginsberg ยท DirectorSince 2023
-
Gary Sender ยท DirectorSince 2023
-
Jeffrey Chodakewitz ยท DirectorSince 2023
-
Kralingen Bridget A. Van ยท DirectorSince 2025
-
Michael Lynton ยท DirectorSince 2023
-
Nancy Thornberry ยท DirectorSince 2023
-
Ramy Farid ยท Director ยท President & CEOSince 2023
-
Richard Friesner ยท DirectorSince 2023
-
Rosana Kapeller-Libermann ยท DirectorSince 2023
Chief executives
Ramy Farid
ยท President & CEO
Dates unknown
Director election results
Annual meeting of June 22, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
75.1%
-
77.8%
-
78.1%
Board connections
8 of this board's directors also sit on 16 other boards.
- via Jeffrey Chodakewitz
- via Gary Sender
- via Michael Lynton
- via Nancy Thornberry
- via Gary Sender
- via Arun Oberoi
- via Jeffrey Chodakewitz
- via Michael Lynton
- via Ramy Farid
- via Kralingen Bridget A. Van
- via Kralingen Bridget A. Van
- via Gary L. Ginsberg
- via Nancy Thornberry
- via Ramy Farid
- via Michael Lynton
- via Gary Sender
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,330,221
- 21 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | Karen Akinsanya Officer (See Remarks) | Option exercise | +31,599 | $4.34 | $137,140 |
| Sep 17, 2026 | Karen Akinsanya Officer (See Remarks) | Open-market sale | โ10,000 | $28.00 | $280,000 |
| Sep 17, 2026 | Karen Akinsanya Officer (See Remarks) | Open-market sale | โ21,599 | $30.00 | $647,970 |
| Jul 16, 2026 | Jain Rachit Officer (EVP & CFO) | Open-market sale | โ875 | $15.60 | $13,647 |
| Jun 26, 2026 | Richard Friesner Director | Gift | โ679,373 | โ | โ |
| Jun 26, 2026 | Richard Friesner Director | Gift | +679,373 | โ | โ |
| Jun 22, 2026 | Arun Oberoi Director | Grant or award | +8,141 | โ | โ |
| Jun 22, 2026 | Jeffrey Chodakewitz Director | Grant or award | +8,141 | โ | โ |
| Jun 22, 2026 | Richard Friesner Director | Grant or award | +8,141 | โ | โ |
| Jun 22, 2026 | Gary L. Ginsberg Director | Grant or award | +8,141 | โ | โ |
| Jun 22, 2026 | Rosana Kapeller-Libermann Director | Grant or award | +8,141 | โ | โ |
| Jun 22, 2026 | Michael Lynton Director | Grant or award | +8,141 | โ | โ |
| Jun 22, 2026 | Gary Sender Director | Grant or award | +8,141 | โ | โ |
| Jun 22, 2026 | Nancy Thornberry Director | Grant or award | +8,141 | โ | โ |
| Jun 22, 2026 | Kralingen Bridget A. Van Director | Grant or award | +8,141 | โ | โ |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.